A yeast screen system for aromatase inhibitors and ligands for androgen receptor: Yeast cells transformed with aromatase and androgen receptor

Environmental Health Perspectives

Volumn 107, Issue 11, 1999, Pages 855-860

  Paul, Mak ^a   Dela Cruz, Fernando ^a   Chen, Shiuan ^b  

^a PFIZER INC   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Androgen receptor; Aromatase; Cytochrome P450; Endocrine disruptors; Yeast screening method

Indexed keywords

AMINOGLUTETHIMIDE; ANDROGEN; ANDROGEN RECEPTOR; ANDROSTENEDIONE; AROMATASE; AROMATASE INHIBITOR; BETA GALACTOSIDASE; CHRYSIN; CYTOCHROME P450; ENVIRONMENTAL CHEMICAL; FLAVONE DERIVATIVE; LIGAND; TESTOSTERONE;

ARTICLE; CELL TRANSFORMATION; ENZYME ACTIVITY; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; SCREENING; TRANSACTIVATION; YEAST CELL;

EID: 0345201750     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.99107855     Document Type: Article

References (30)

1. MacLusky NJ, Clark AS, Naftolin F, Goldman-Rakic PS. Estrogen formation in the mammalian brain: possible role of aromatase in sexual differentiation of the hippocampus and neocortex. Steroids 50:459-474 (1987).
2. Miller WR, O'Neill J. The importance of local synthesis of estrogen within the breast. Steroids 50:537-548 (1987).
3. Silva MC, Rowlands MG, Oowsett M, Gusterson B, McKinna JA, Fryatt I, Coombes RC. Intratumoral aromatase as a prognostic factor in human breast carcinoma. Cancer Res 49:2588-2591 (1989).
4. Reed MJ, Owen AM, Lai LC, Coldham NG, Ghilchik MW, Shaikh NA, James VHT. In situ oestrone synthesis in normal breast and breast tumor tissues: effect of treatment with 4-hydroxyandrostenedione. Int J Cancer 44:233-237 (1989).
5. Brodie AMH, Schwarzel WC, Shaikh AA, Brodie H. The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen dependent processes in reproduction and breast cancer. Endocrinology 100:1684-1695 (1977).
6. Salhanick HA. Basic studies on aminoglutethimide. Cancer Res 42 (suppl):S3315-S3321 (1982).
7. De Rosa C, Richter P, Pohl H, Jones DE. Environmental exposures that affect the endocrine system: public health implications. J Toxicol Environ Health B Crit Rev 1:3-26 (1998).
8. Santti R, Makela S, Strauss L, Korkman J, Kostian ML Phytoestrogens: potential endocrine disruptors in males. Toxicol Ind Health 14:223-237 (1998).
9. Toppari J, Skakkebaek NE. Sexual differentiation and environmental endocrine disruptors. Baillieres Clin Endocrinol Metab 12:143-156 (1998).
10. Soto AM, Michaelson CL, Prechtl NV, Weill BC, Sonnenschein C, Olea-Serrano F, Olea N. Assays to measure estrogen and androgen agonists and antagonists. Adv Exp Med Biol 444:9-23 (1998).
11. Kelce WR, Gray LE, Wilson EM. Antiandrogens as environmental endocrine disruptors. Reprod Fertil Dev 10:105-111 (1998).
12. Sonnenschein C, Soto AM. An updated review of environmental estrogen and androgen mimics and antagonists. J Steroid Biochem Mol Biol 65:143-150 (1998).
13. Kao YC, Zhou C, Sherman M, Laughton CA, Chen S. Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: a site-directed mutagenesis study. Environ Health Perspect 106:85-92 (1998).
14. Kellis JT, Vickery LE. Inhibition of estrogen systhetase (aromatase) by flavones. Science 225:1032-1034 (1984).
15. Wang C, Makela T, Hase T, Adlercreutz H, Kurzer MS. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem Mol Biol 50:205-212 (1994).
16. Zhou D, Pompon D, Chen S. Stable expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening. Cancer Res 50:6949-6954 (1990).
17. Moehle CM, Ayanardi MW, Kolodny MR, Park FJ, Jones EW. Protease B of Saccharomyces cerevisiae: isolation and regulation of the PRBI structural gene. Genetics 115:255-263 (1987).
18. Mak P, McDonnell DP, Weigel NL, Schrader WT, O'Malley BW. Expression of functional chicken progesterone receptor in yeast (Saccharomyces cerevisiae). J Biol Chem 264:21613-21618 (1989).
19. Sherman F, Fink GR, Hicks JB. A Laboratory Manual. Cold Spring Harbor, NY:Cold Spring Harbor Laboratory, 1982.
20. Mak P, Young CYF, Tindall DJ. A novel yeast expression system to study androgen action. Recent Prog Horm Res 49:347-452 (1994).
21. Bagchi MK, Elliston JF, Tsai SY, Edwards DP, Tsai MJ, O'Malley BW. Steroid hormone-dependent interaction of human progesterone receptor with its target enhancer element. Mol Endocrinol 2:1221-1229 (1988).
22. Pompon D, Liu RYK, Besman MJ, Wang PL, Shively JE, Chen S. Expression of human placental aromatase in Saccharomyces cerevisiae. Mol Endocrinol 3:1477-1487 (1989).
23. Thompson EA Jr, Siiteri PK. Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. J Biol Chem 249:5364-5372 (1974).
24. Mak P, Fuernkranz HA, Ge R, Karathanasis SK. RXRα homodimers function as transcriptional activators in yeast. Gene 145:129-133 (1994).
25. Salerno AJ, He Z, Goos-Nilsson A, Ahola H, Mak P. Differential transcriptional regulation of the apoAI gene by retinoic acid receptor homo- and heterodimers in yeast. Nucleic Acid Res 24:566-572 (1996).
26. Kao YC, Higashiyama T, Yarborough C, Osawa Y, Chen S. Functional characterization of 102-amino acid-deleted form of human aromatase. Steroids 64:422-429 (1999).
27. Dowsett M. Clinical development of aromatase inhibitors for the treatment of breast and prostate cancer. J Steroid Biochem Mol Biol 37:1037-1041 (1990).
28. Brodie A. Aromatase and its inhibitors - an overview. J Steroid Biochem Mol Biol 40:255-261 (1991).
29. Dowsett M, Coombes RC. Second generation aromatase inhibitor - 4-hydroxyandrostenedione. Breast Cancer Res Treat 30:81-87 (1994).
30. Davies JH, Shearer RJ, Rowlands MG, Poon GK, Houghton J, Jarman M, Dowsett M. Effects of 4-hydroxyandrost-4-ene-3,17-dione and its metabolites on 5 alpha-reductase activity and androgen receptor. J Enzyme Inhib 6:141-147 (1992).